BSE Live
Jan 22, 16:01Prev. Close
839.85
Open Price
840.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 22, 15:59Prev. Close
839.75
Open Price
844.95
Bid Price (Qty.)
834.75 (291)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Natco Pharma (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 33.23 | 33.07 | 31.37 | 31.15 | 28.15 | |
| Total Share Capital | 33.23 | 33.07 | 31.37 | 31.15 | 28.15 | |
| Reserves and Surplus | 845.76 | 699.83 | 506.21 | 436.32 | 318.76 | |
| Total Reserves and Surplus | 845.76 | 699.83 | 506.21 | 436.32 | 318.76 | |
| Total Shareholders Funds | 878.99 | 732.90 | 537.58 | 467.46 | 346.91 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 96.28 | 94.97 | 137.12 | 134.10 | 125.43 | |
| Deferred Tax Liabilities [Net] | 11.29 | 42.33 | 41.12 | 28.89 | 25.09 | |
| Other Long Term Liabilities | 0.77 | 0.69 | 0.69 | 1.35 | 1.25 | |
| Long Term Provisions | 9.19 | 10.63 | 8.21 | 9.78 | 8.67 | |
| Total Non-Current Liabilities | 117.53 | 148.62 | 187.15 | 174.12 | 160.44 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 168.54 | 98.63 | 147.74 | 81.64 | 72.02 | |
| Trade Payables | 115.34 | 99.18 | 104.42 | 83.86 | 72.99 | |
| Other Current Liabilities | 113.32 | 96.48 | 80.25 | 81.84 | 43.65 | |
| Short Term Provisions | 1.11 | 0.41 | 0.33 | 0.24 | 0.12 | |
| Total Current Liabilities | 398.31 | 294.71 | 332.75 | 247.58 | 188.78 | |
| Total Capital And Liabilities | 1,394.84 | 1,176.22 | 1,057.48 | 889.17 | 696.13 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 568.02 | 523.19 | 465.65 | 300.03 | 252.45 | |
| Intangible Assets | 4.71 | 5.79 | 4.91 | 1.78 | 1.70 | |
| Capital Work-In-Progress | 100.77 | 92.94 | 78.37 | 164.43 | 75.98 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 673.51 | 621.92 | 548.92 | 466.23 | 330.13 | |
| Non-Current Investments | 131.15 | 88.58 | 76.76 | 74.16 | 69.05 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 142.47 | 125.16 | 120.66 | 54.91 | 62.46 | |
| Other Non-Current Assets | 3.52 | 3.22 | 0.13 | 0.42 | 0.96 | |
| Total Non-Current Assets | 950.65 | 838.88 | 746.47 | 595.72 | 462.59 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.12 | 0.32 | 0.81 | 1.79 | 2.14 | |
| Inventories | 198.35 | 161.97 | 128.32 | 97.28 | 93.02 | |
| Trade Receivables | 188.96 | 115.85 | 126.46 | 93.34 | 70.37 | |
| Cash And Cash Equivalents | 7.19 | 7.70 | 9.37 | 33.70 | 30.97 | |
| Short Term Loans And Advances | 47.66 | 49.00 | 42.69 | 66.21 | 36.92 | |
| OtherCurrentAssets | 1.91 | 2.52 | 3.35 | 1.14 | 0.11 | |
| Total Current Assets | 444.18 | 337.35 | 311.00 | 293.45 | 233.54 | |
| Total Assets | 1,394.84 | 1,176.22 | 1,057.48 | 889.17 | 696.13 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 19.26 | 42.54 | 37.41 | 52.07 | 70.82 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 36.99 | 33.94 | 37.56 | 16.75 | 16.96 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 16.83 | 8.18 | 11.04 | 22.07 | 15.35 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 42.05 | 28.16 | 14.18 | 12.35 | 12.16 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | 0.03 | 0.27 | 0.22 | 0.16 | 0.11 | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 286.63 | 290.78 | 281.74 | 179.02 | 130.09 | |
| Other Earnings | 28.93 | 84.95 | 38.74 | 7.63 | 9.82 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 5.81 | 5.81 | 5.81 | 5.81 | 5.81 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 131.15 | 88.58 | 76.76 | 74.16 | 69.05 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 0.70 | 2.06 | 1.38 | 0.74 | 0.85 | |
| Current Investments Unquoted Book Value | -- | -- | -- | 1.05 | 1.32 |
26.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
24.11.2025
Natco Pharma Standalone September 2025 Net Sales at Rs 1,264.30 crore, down 2.19% Y-o-Y
24.11.2025
24.11.2025
26.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
24.11.2025
Natco Pharma Standalone September 2025 Net Sales at Rs 1,264.30 crore, down 2.19% Y-o-Y
14.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
09.09.2025
Natco Pharma Standalone June 2025 Net Sales at Rs 1,192.70 crore, down 3.57% Y-o-Y